These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 22498679)

  • 1. [Pharmacological treatment strategies targeting cognitive impairment associated with aging].
    Koh MT
    Nihon Yakurigaku Zasshi; 2012 Apr; 139(4):157-9. PubMed ID: 22498679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective GABA(A) α5 positive allosteric modulators improve cognitive function in aged rats with memory impairment.
    Koh MT; Rosenzweig-Lipson S; Gallagher M
    Neuropharmacology; 2013 Jan; 64(1):145-52. PubMed ID: 22732440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Response of the medial temporal lobe network in amnestic mild cognitive impairment to therapeutic intervention assessed by fMRI and memory task performance.
    Bakker A; Albert MS; Krauss G; Speck CL; Gallagher M
    Neuroimage Clin; 2015; 7():688-98. PubMed ID: 25844322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased hippocampal activation in ApoE-4 carriers and non-carriers with amnestic mild cognitive impairment.
    Tran TT; Speck CL; Pisupati A; Gallagher M; Bakker A
    Neuroimage Clin; 2017; 13():237-245. PubMed ID: 28070483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment strategies targeting excess hippocampal activity benefit aged rats with cognitive impairment.
    Koh MT; Haberman RP; Foti S; McCown TJ; Gallagher M
    Neuropsychopharmacology; 2010 Mar; 35(4):1016-25. PubMed ID: 20032967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction of hippocampal hyperactivity improves cognition in amnestic mild cognitive impairment.
    Bakker A; Krauss GL; Albert MS; Speck CL; Jones LR; Stark CE; Yassa MA; Bassett SS; Shelton AL; Gallagher M
    Neuron; 2012 May; 74(3):467-74. PubMed ID: 22578498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GABA(A) receptor subtype selective cognition enhancers.
    Maubach K
    Curr Drug Targets CNS Neurol Disord; 2003 Aug; 2(4):233-9. PubMed ID: 12871033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insight into Novel Treatment for Cognitive Dysfunctions across Disorders.
    Prevot TD; Li G; Cook JM; Sibille E
    ACS Chem Neurosci; 2019 May; 10(5):2088-2090. PubMed ID: 30920790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting Neural Hyperactivity as a Treatment to Stem Progression of Late-Onset Alzheimer's Disease.
    Haberman RP; Branch A; Gallagher M
    Neurotherapeutics; 2017 Jul; 14(3):662-676. PubMed ID: 28560709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quieting the overactive hippocampus restores memory in aging.
    Baxter MG
    Trends Cogn Sci; 2012 Jul; 16(7):360-1. PubMed ID: 22673053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective inhibition of extra-synaptic α5-GABA
    Etherington LA; Mihalik B; Pálvölgyi A; Ling I; Pallagi K; Kertész S; Varga P; Gunn BG; Brown AR; Livesey MR; Monteiro O; Belelli D; Barkóczy J; Spedding M; Gacsályi I; Antoni FA; Lambert JJ
    Neuropharmacology; 2017 Oct; 125():353-364. PubMed ID: 28807671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. γ-Aminobutyric acid type A (GABA(A)) receptor subtype inverse agonists as therapeutic agents in cognition.
    Gabriella G; Giovanna C
    Methods Enzymol; 2010; 485():197-211. PubMed ID: 21050918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of ageing reveals distinct roles for human dentate gyrus and CA3 in pattern separation and object recognition memory.
    Dillon SE; Tsivos D; Knight M; McCann B; Pennington C; Shiel AI; Conway ME; Newson MA; Kauppinen RA; Coulthard EJ
    Sci Rep; 2017 Oct; 7(1):14069. PubMed ID: 29070813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A cognitive electrophysiological signature differentiates amnestic mild cognitive impairment from normal aging.
    Li J; Broster LS; Jicha GA; Munro NB; Schmitt FA; Abner E; Kryscio R; Smith CD; Jiang Y
    Alzheimers Res Ther; 2017 Jan; 9(1):3. PubMed ID: 28100252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hippocampal subfield volumes at 7T in early Alzheimer's disease and normal aging.
    Wisse LE; Biessels GJ; Heringa SM; Kuijf HJ; Koek DH; Luijten PR; Geerlings MI;
    Neurobiol Aging; 2014 Sep; 35(9):2039-45. PubMed ID: 24684788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring the Profile of Incidental Memory in Patients with Amnestic Mild Cognitive Impairment and Mild Alzheimer's Disease.
    Kontaxopoulou D; Beratis IN; Fragkiadaki S; Pavlou D; Andronas N; Yannis G; Economou A; Papanicolaou AC; Papageorgiou SG
    J Alzheimers Dis; 2018; 65(2):617-627. PubMed ID: 30056423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Self-reference effect on memory in healthy aging, mild cognitive impairment and Alzheimer's disease: Influence of identity valence.
    Leblond M; Laisney M; Lamidey V; Egret S; de La Sayette V; Chételat G; Piolino P; Rauchs G; Desgranges B; Eustache F
    Cortex; 2016 Jan; 74():177-90. PubMed ID: 26691733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective effect of compound Danshen (Salvia miltiorrhiza) dripping pills alone and in combination with carbamazepine on kainic acid-induced temporal lobe epilepsy and cognitive impairment in rats.
    Jia C; Han S; Wei L; Dang X; Niu Q; Chen M; Cao B; Liu Y; Jiao H
    Pharm Biol; 2018 Dec; 56(1):217-224. PubMed ID: 29560767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conversion pattern and predictive factor of mild cognitive impairment in elderly Koreans.
    Shim SM; Song J; Kim JH; Jeon JP
    Arch Gerontol Geriatr; 2016; 64():146-50. PubMed ID: 26896864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in vivo properties of 3-tert-butyl-7-(5-methylisoxazol-3-yl)-2-(1-methyl-1H-1,2,4-triazol-5-ylmethoxy)-pyrazolo[1,5-d]-[1,2,4]triazine (MRK-016), a GABAA receptor alpha5 subtype-selective inverse agonist.
    Atack JR; Maubach KA; Wafford KA; O'Connor D; Rodrigues AD; Evans DC; Tattersall FD; Chambers MS; MacLeod AM; Eng WS; Ryan C; Hostetler E; Sanabria SM; Gibson RE; Krause S; Burns HD; Hargreaves RJ; Agrawal NG; McKernan RM; Murphy MG; Gingrich K; Dawson GR; Musson DG; Petty KJ
    J Pharmacol Exp Ther; 2009 Nov; 331(2):470-84. PubMed ID: 19704033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.